Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

More research is needed to understand how testosterone is maintained in adult males.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Exercise and finasteride together improve ovary health in PCOS rats.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Vitamin D is important for bones, hair, blood pressure, and breast development.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

μ-Crystallin may help hair growth by affecting thyroid hormone levels in mouse hair follicles.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.